<DOC>
	<DOCNO>NCT01111994</DOCNO>
	<brief_summary>The purpose study ascertain efficacy safety Clindamycin Phosphate 1.2 % Tretinoin 0.025 % treatment Acne Post Inflammatory Hyperpigmentation patient skin color .</brief_summary>
	<brief_title>Efficacy &amp; Safety Clindamycin Tretinoin Acne</brief_title>
	<detailed_description>Acne chronic disorder pilosebaceous gland characterize inflammatory papule , pustule , open closed comedo , cyst nodule . Post inflammatory hyperpigmentation condition inflammation disease acne , trauma , abrasion result area skin increase melanin content compare surround skin . There several treatment available acne , include benzoyl peroxide , antibiotic ( topical oral ) , topical retinoids ( tretinoin , tazarotene , adapalene ) . Combination therapy , topical retinoid clindamycin , show effective monotherapy address pathogenic factor acne .</detailed_description>
	<mesh_term>Hyperpigmentation</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>Mild moderate facial acne mild moderate postinflammatory hyperpigmentation Photo skin type IV VI Ages 12 old Both sex Two week washout period topical antiacne medication , medicate cosmetic , bleach product Thirty day washout period oral corticosteroid , oral antibiotic , oral contraceptive Seborrheic dermatitis PIH solely dermal origin Acne vulfaris know resistant oral antibiotic Use erythromycincontaining product Use neuromuscular block agent Pregnancy , breastfeeding , positive pregnancy test office , plan become pregnant . Women childbearing age must use reliable form contraception ( e.g. , abstinence , oral contraceptive , spermicide condom ) .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>hyperpigmentation</keyword>
</DOC>